Tenebro, Antonio C.
HRN: 27-93-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/08/2025
10/15/2025
IV
600MG
Q6
INFECTED DECUBITUS ULCER
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes